Skip to content
10-Q

Quarterly Report

AVEO Pharmaceuticals, Inc.

0001628280-22-021160

← back to feed
Filed
Aug 4, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 1, 2022 34.61M sh
Shares Diluted Q2 2022 · Jun 30, 2022 34.5M sh
Shares Diluted Q2 2022 · Jun 30, 2022 34.49M sh
Shares Diluted Q2 2022 · Jun 30, 2021 34.36M sh
Shares Diluted Q2 2022 · Jun 30, 2021 30.92M sh
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$10.67M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$37M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $70.17M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $70.54M
Stockholders Equity Q2 2022 · Jun 30, 2022 $30.59M
Stockholders Equity Q2 2022 · Mar 31, 2022 $36.94M
Stockholders Equity Q2 2022 · Dec 31, 2021 $45.87M
Stockholders Equity Q2 2022 · Jun 30, 2021 $60.2M
Stockholders Equity Q2 2022 · Mar 31, 2021 $72.56M
Stockholders Equity Q2 2022 · Dec 31, 2020 $35.29M
Current Liabilities Q2 2022 · Jun 30, 2022 $31.5M
Current Liabilities Q2 2022 · Dec 31, 2021 $18.73M
Total Liabilities Q2 2022 · Jun 30, 2022 $67.52M
Total Liabilities Q2 2022 · Dec 31, 2021 $59.47M
Current Assets Q2 2022 · Jun 30, 2022 $97.59M
Current Assets Q2 2022 · Dec 31, 2021 $104.74M
Total Assets Q2 2022 · Jun 30, 2022 $98.11M
Total Assets Q2 2022 · Dec 31, 2021 $105.34M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.24
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.54
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.40
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.16
Eps Basic Q2 2022 · Jun 30, 2022 −$0.24
Eps Basic Q2 2022 · Jun 30, 2022 −$0.54
Eps Basic Q2 2022 · Jun 30, 2021 −$0.40
Eps Basic Q2 2022 · Jun 30, 2021 −$1.16
Sga Expense Q2 2022 · Jun 30, 2022 $17.08M
Sga Expense Q2 2022 · Jun 30, 2022 $34.41M
Sga Expense Q2 2022 · Jun 30, 2021 $14.92M
Sga Expense Q2 2022 · Jun 30, 2021 $30.02M
Rd Expense Q2 2022 · Jun 30, 2022 $12.32M
Rd Expense Q2 2022 · Jun 30, 2022 $22.48M
Rd Expense Q2 2022 · Jun 30, 2021 $6.88M
Rd Expense Q2 2022 · Jun 30, 2021 $12.68M
Net Income Q2 2022 · Jun 30, 2022 −$8.32M
Net Income Q2 2022 · Jun 30, 2022 −$18.52M
Net Income Q2 2022 · Mar 31, 2022 −$10.2M
Net Income Q2 2022 · Jun 30, 2021 −$13.6M
Net Income Q2 2022 · Jun 30, 2021 −$35.72M
Net Income Q2 2022 · Mar 31, 2021 −$22.12M
Operating Income Q2 2022 · Jun 30, 2022 −$7.15M
Operating Income Q2 2022 · Jun 30, 2022 −$16.17M
Operating Income Q2 2022 · Jun 30, 2021 −$15.06M
Operating Income Q2 2022 · Jun 30, 2021 −$34.18M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $3.07M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $5.5M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $822K
Cost Of Revenue Q2 2022 · Jun 30, 2021 $960K
Revenue Q2 2022 · Jun 30, 2022 $25.3M
Revenue Q2 2022 · Jun 30, 2022 $46.22M
Revenue Q2 2022 · Jun 30, 2021 $7.56M
Revenue Q2 2022 · Jun 30, 2021 $9.48M